2.
Association between HPV load and clinicopathological characteristics
| Characteristics | ≤Median | >Median | All | P |
| HPV, human papillomavirus; RH, radical hysterectomy; CCRT, concurrent chemoradiotherapy; FIGO, International Federation of Gynecology and Obstetrics; LNSCT, lymph node status determined by computed tomography; Single LN, single lymph node diameter; Multi LNs, multiple lymph nodes diameter. | ||||
| RH group tumor size (cm) | ||||
| ≤2 | 50 | 26 | 76 | 0.002 |
| >2 | 130 | 154 | 284 | |
| CCRT group tumor size (cm) | ||||
| ≤4 | 30 | 17 | 47 | 0.024 |
| >4 | 50 | 63 | 113 | |
| CCRT group FIGO stage | ||||
| IIB/IIIA | 49 | 66 | 115 | 0.020 |
| IIIB/IVA | 31 | 14 | 45 | |
| CCRT group LNSCT [n (%)] | ||||
| No LN | 32 (40.00) | 48 (60.00) | 80 (50.00) | 0.030 |
| LN diameter ≤1 cm | 14 (17.50) | 15 (18.75) | 29 (18.13) | |
| Single LN >1 cm | 15 (18.75) | 7 (8.75) | 22 (13.75) | |
| Multi LNs >1 cm | 19 (23.75) | 10 (12.50) | 29 (18.13) | |